DMSFX
Price
$10.31
Change
+$0.02 (+0.19%)
Updated
Jul 31 closing price
Net Assets
577.29M
GSRTX
Price
$11.18
Change
+$0.04 (+0.36%)
Updated
Jul 31 closing price
Net Assets
6.27B
Interact to see
Advertisement

DMSFX vs GSRTX

DMSFX vs GSRTX Comparison Chart in %
View a ticker or compare two or three
VS
DMSFX vs. GSRTX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMSFX is a Hold and GSRTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSRTX has more cash in the bank: 6.27B vs. DMSFX (577M). DMSFX pays higher dividends than GSRTX: DMSFX (3.57) vs GSRTX (0.37). DMSFX was incepted earlier than GSRTX: DMSFX (9 years) vs GSRTX (18 years). DMSFX (1.69) is less costly to investors than GSRTX (0.91). GSRTX is a more actively managed with annual turnover of: 134.00 vs. DMSFX (55.00). DMSFX (0) and GSRTX (0) have matching initial minimum investment requirements. GSRTX annual gain was more profitable for investors over the last year : 9.72 vs. DMSFX (3.66). DMSFX return over 5 years is better than : 20.43 vs. GSRTX (16.29).
DMSFXGSRTXDMSFX / GSRTX
Total Expense Ratio1.330.85156%
Annual Report Gross Expense Ratio1.690.91186%
Fund Existence9 years18 years-
Gain YTD1.1186.07218%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets577M6.27B9%
Annual Yield % from dividends3.570.37956%
Returns for 1 year3.669.7238%
Returns for 3 years17.7325.1171%
Returns for 5 years20.4316.29125%
Returns for 10 yearsN/A37.75-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWRE1.200.05
+4.35%
Aware
EGHT1.900.05
+2.70%
8x8
PFE25.010.10
+0.40%
Pfizer
ERAS18.15-0.53
-2.84%
Erasca
FMC10.71-1.12
-9.47%
FMC Corp